Keyphrases
Therapeutic Vaccination
100%
Survivin
100%
HLA-A24
100%
Survivin-2B
83%
Epitope
66%
Splice Variant
33%
Immune Response
16%
Asia
16%
Cancer Patients
16%
Vaccination
16%
CD8+
16%
Cytotoxic T Cells
16%
Tumor Stage
16%
HLA Alleles
16%
Advanced Colorectal Cancer
16%
Tumor Invasion
16%
Tumor Differentiation
16%
Pro-apoptotic
16%
Recurrent Colorectal Cancer
16%
Malignant Tissue
16%
Survivin Splice Variants
16%
Peptide Immunotherapy
16%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Vaccination Policy
100%
Survivin
100%
HLA A24 Antigen
100%
Epitope
33%
Immunotherapy
16%
Neoplasm
8%
Cancer Staging
8%
Clinical Study
8%
Colorectal Cancer
8%
CD8 Antigen
8%
Immunology and Microbiology
Vaccination Policy
100%
HLA A24 Antigen
100%
Epitope
80%
Immunotherapy
40%
Immune Response
20%
Allele
20%
Cytotoxic T Cell
20%
CD8
20%
Cancer Staging
20%